An official website of the State of Oregon
Here's how you know »
An official website of the State of Oregon »
You are here:
Shelley Bailey served as the CEO and co-owner of Central Drugs pharmacy. She is currently the CEO of Famlee, the nation’s first and only 50-state virtual fertility care and treatment option (combining at-home labs with fertility telehealth and Rx delivery).Shelley has been involved in health care since she was a young girl starting in the days when her grandparents owned a small independent pharmacy in the Mt. Tabor neighborhood of Portland. Under her leadership, Central Drugs was the largest contractor for the state’s AIDS Drug Assistance Program (ADAP), serving Oregonians living with HIV and Hepatitis C. Shelley has direct experience with specialty pharmacy, wholesaler price negotiations, manufacturer negotiations, PBM contract negotiations, and 340B arrangements.Previously, Shelley served on the Oregon 2012 Pharmacy Benefit Manager Legislative Committee (House Bill 4122). In addition, she is a former member of the McKesson National Independent Advisory Board and has served on state and national pharmacy advocacy committees. Shelley looks to bring her direct knowledge of pharmacy into wider discussions on effectively saving money on prescription drug costs for the State and for all Oregonians.
Richard Bruno, MD, MPH
Richard Bruno, MD, MPH, is a double-boarded Family & Preventive medicine physician, practicing as the senior medical director at Central City Concern, a federally-qualified health center in Portland that has an integrated 340B pharmacy.His main clinical focuses are on houselessness, HIV, transcare, obesity, and opioids, with involvement in community public health interventions and policies, including cooking classes for kids/seniors and legislation expanding access to medication for opioid use disorder.Dr. Bruno passionately believes no one should have to choose between life-saving medications and other necessities. As a primary care physician, he often runs into barriers trying to get his patients access to the medications they need and states it would be an honor to serve on the PDAB to look at drug pricing and make improvements for all Oregonians.
Dan Hartung PharmD, MPH
Dan Hartung PharmD, MPH is a tenured professor of pharmacy practice in the College of Pharmacy at Oregon State University.Over the last two decades he has conducted pharmaceutical health services research with an emphasis on substance use disorders and prescription drug policy. Dr. Hartung’s work has been supported by several federal agencies including AHRQ, CDC, and NIH (NIDA) and he has published over 100 papers in the peer-reviewed medical literature.His research portfolio involves investigating the causes and consequences of rising prescription drug costs with a specific emphasis on medications for multiple sclerosis (MS). Through this work, he has developed a deep understanding about how the dysfunctional pharmaceutical ecosystem has contributed to rising prescription drug prices and expenditures.As a health services researcher and pharmacist, he is well positioned to serve on this board to assist the state in its development of informed policy to address prescription drug affordability challenges for Oregonians.
Akil Patterson, JD, MLS, PCM
Akil Patterson JD, MLS, PCM was involved in advocacy efforts for the creation of PDABs in Oregon as a member of the Oregon Coalition for Affordable Prescriptions (OCAP) and in Maryland where he previously resided. He is a passionate in his advocacy that poor and people of color have access to the same lifesaving medications as others.Mr. Patterson is former a political organizer for the Oregon Nurses Association where he lead trainings around diversity and inclusion, and efforts to address the social determinants of health in health policy reforms. Currently Mr. Patterson serves as the city of Portland social equity and educational development coordinator for the cannabis program.Mr. Patterson has worked throughout his career as a champion of social justice and racial equity issues and was awarded a Presidential Service Award in 2016 by President Barack Obama. He has served in a number of leadership roles including the Maryland State Medical Society's Sugar-Free Kids Project and Aids Healthcare Foundation.
Robert Judge is the director of Pharmacy Services at Moda. In this role, Robert is responsible for managing Moda Health’s pharmacy account services and data analytics teams for the company’s fully insured, ASO and MCO clients.Robert also manages pharmacy programs, services and analytics for Moda Health’s government clients and individuals enrolled in ArrayRx (formerly the Northwest Prescription Drug Consortium), a collaboration between the states of Oregon, Washington, and Nevada to provide pharmacy solutions and affordable medications to residents in member states.He has expertise in payer pharmaceutical acquisition pricing, pharmacy benefit management services, pharmaceutical distribution, supply chain, and public health service 340B program management.
Rebecca Spain, MD, MSPH
Rebecca Spain MD, MSPH, is an associate professor in the Department of Neurology at OHSU, associate director of clinical care for the Multiple Sclerosis (MS) Veteran’s Administration (VA) Center of Excellence West, and MS regional director for the VA Portland Health Care System.As a neurologist specializing in MS, she sees firsthand the devastating effects of high cost prescription drugs on patients and their families. Noting these effects result in poorer health outcomes, economic devastation, and a loss of social cohesion, Dr. Spain hopes to contribute to the PDAB with her knowledge, experience, and advocacy.
A .gov website belongs to an official government organization in the United States.
A lock icon ( ) or https:// means you’ve safely connected to the .gov website.
Only share sensitive information on official, secure websites.
Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how